Compound name
CGI1746
Protein family
Protein Kinase
Target name
BTK
Affinity biochemical (nM)
1.9
CG-Set
Kinase set
Recommended Concentration
1 µM
Compound EUbOPEN ID
EUB0000158b
SMILES
Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1
InChIKey
JIFCFQDXHMUPGP-UHFFFAOYSA-N
NCBI gene ID
695
UniProt ID
Q06187
Synonyms
ATK, XLA, PSCTK1
Mode of action
Inhibitor
Affinity biochemical definition
IC50
Affinity biochemical assay type
Lanthascreen assay (using 10 µM ATP)
Affinity Biochemical Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/21113169/
Affinity biochemical relation
=
Selectivity platform
KinomeScan (Ambit)
Selectivity platform number of targets
386
Selectivity remarks
Screened at 1 µM, closest targets as % of control: BTK (1%), CASK (41%); Kd follow-up of closest targets: Kd(BTK) = 1.5 nM, Kd(MINK1) = 40 µM; Screened at 1 µM (Kinase panel, UBI KinaseProfiler, 205 kinases Millipore screen, using Km = ATP), closest target as % of control: BTK (99%), FES(53%); Kinase panel (Enzymatic assay, 47 kinases, using Km = ATP) in-vitro potency of closest targets: IC50(BLK) = 7573 nM, IC50(BMX) = 1870 nM, IC50(ITK) = 4270 nM, IC50(PDGFRB) = 2440 nM, IC50(SRC) = 3650 nM, IC50(NTRK1) = 1885 nM, IC50(FLT4) = 3287 nM, others IC50 >10 µM; Screened at 1 µM against 82 non-kinase targets (CEREP screen), closest targets as % of inhibition: Adenosine A1 (31%), Adenosine A2A (34%), https://pubmed.ncbi.nlm.nih.gov/21113169/;
Selectivity Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/21113169/
Selectivity Number of Off-targets
0